AAAAAA

   
Results: 1-8 |
Results: 8
Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects
Authors: Swan, SK St Peter, JV Lambrecht, LJ Hursting, MJ
Citation: Sk. Swan et al., Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects, PHARMACOTHE, 20(7), 2000, pp. 756-770
Pharmacokinetics of pilocarpine in subjects with varying degrees of renal function
Authors: St Peter, JV Lambrecht, LJ Gunderson, BW Andersen, SA Gallagher, SC Swan, SK
Citation: Jv. St Peter et al., Pharmacokinetics of pilocarpine in subjects with varying degrees of renal function, J CLIN PHAR, 40(12), 2000, pp. 1470-1475
Effect of cyclooxygenase-2 inhibition on renal function in elderly personsreceiving a low-salt diet - A randomized, controlled trial
Authors: Swan, SK Rudy, DW Lasseter, KC Ryan, CF Buechel, KL Lambrecht, LJ Pinto, MB Dilzer, SC Obrda, O Sundblad, KJ Gumbs, CP Ebel, DL Quan, H Larson, PJ Schwartz, JI Musliner, TA Gertz, BJ Brater, DC Yao, SL
Citation: Sk. Swan et al., Effect of cyclooxygenase-2 inhibition on renal function in elderly personsreceiving a low-salt diet - A randomized, controlled trial, ANN INT MED, 133(1), 2000, pp. 1-9
Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function
Authors: Swan, SK Baker, JF Free, R Tucker, RM Barron, B Barr, R Seltzer, S Gazelle, GS Maravilla, KR Barr, W Stevens, GR Lambrecht, LJ Pierro, JA
Citation: Sk. Swan et al., Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function, J MAGN R I, 9(2), 1999, pp. 317-321
Pharmacokinetics of flutamide in patients with renal insufficiency
Authors: Anjum, S Swan, SK Lambrecht, LJ Radwanski, E Cutler, DL Affrime, MB Halstenson, CE
Citation: S. Anjum et al., Pharmacokinetics of flutamide in patients with renal insufficiency, BR J CL PH, 47(1), 1999, pp. 43-47
Disposition of recombinant human interleukin-10 in subjects with various degrees of renal function
Authors: Andersen, SR Lambrecht, LJ Swan, SK Cutler, DL Radwanski, E Affrime, MB Garaud, JJ
Citation: Sr. Andersen et al., Disposition of recombinant human interleukin-10 in subjects with various degrees of renal function, J CLIN PHAR, 39(10), 1999, pp. 1015-1020
The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects
Authors: Mathur, VS Swan, SK Lambrecht, LJ Anjum, S Fellmann, J McGuire, D Epstein, M Luther, RR
Citation: Vs. Mathur et al., The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects, CRIT CARE M, 27(9), 1999, pp. 1832-1837
Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment
Authors: Swan, SK Lambrecht, LJ Townsend, R Davies, BE McCloud, S Parker, JR Bensel, K LaFrance, ND
Citation: Sk. Swan et al., Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment, INV RADIOL, 34(7), 1999, pp. 443-448
Risultati: 1-8 |